Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2002 1
2004 1
2005 1
2006 1
2007 1
2008 2
2010 2
2011 4
2012 9
2013 5
2014 6
2015 13
2016 5
2017 7
2018 9
2019 6
2020 15
2021 20
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year
Filters applied: . Clear all
Page 1
Schistosomiasis-from immunopathology to vaccines.
McManus DP, Bergquist R, Cai P, Ranasinghe S, Tebeje BM, You H. McManus DP, et al. Among authors: ranasinghe s. Semin Immunopathol. 2020 Jun;42(3):355-371. doi: 10.1007/s00281-020-00789-x. Epub 2020 Feb 19. Semin Immunopathol. 2020. PMID: 32076812 Free PMC article. Review.
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.
Schoenfeld JD, Giobbie-Hurder A, Ranasinghe S, Kao KZ, Lako A, Tsuji J, Liu Y, Brennick RC, Gentzler RD, Lee C, Hubbard J, Arnold SM, Abbruzzese JL, Jabbour SK, Uboha NV, Stephans KL, Johnson JM, Park H, Villaruz LC, Sharon E, Streicher H, Ahmed MM, Lyon H, Cibuskis C, Lennon N, Jhaveri A, Yang L, Altreuter J, Gunasti L, Weirather JL, Mak RH, Awad MM, Rodig SJ, Chen HX, Wu CJ, Monjazeb AM, Hodi FS. Schoenfeld JD, et al. Among authors: ranasinghe s. Lancet Oncol. 2022 Feb;23(2):279-291. doi: 10.1016/S1470-2045(21)00658-6. Epub 2022 Jan 13. Lancet Oncol. 2022. PMID: 35033226 Clinical Trial.
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer.
Monjazeb AM, Giobbie-Hurder A, Lako A, Thrash EM, Brennick RC, Kao KZ, Manuszak C, Gentzler RD, Tesfaye A, Jabbour SK, Alese OB, Rahma OE, Cleary JM, Sharon E, Mamon HJ, Cho M, Streicher H, Chen HX, Ahmed MM, Mariño-Enríquez A, Kim-Schulze S, Gnjatic S, Maverakis E, Marusina AI, Merleev AA, Severgnini M, Pfaff KL, Lindsay J, Weirather JL, Ranasinghe S, Spektor A, Rodig SJ, Hodi SF, Schoenfeld JD. Monjazeb AM, et al. Among authors: ranasinghe s. Clin Cancer Res. 2021 May 1;27(9):2470-2480. doi: 10.1158/1078-0432.CCR-20-4632. Epub 2021 Feb 10. Clin Cancer Res. 2021. PMID: 33568343 Free PMC article.
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Alva AS, Mangat PK, Garrett-Mayer E, Halabi S, Hansra D, Calfa CJ, Khalil MF, Ahn ER, Cannon TL, Crilley P, Fisher JG, Haslem DS, Shrestha S, Antonelli KR, Butler NL, Warren SL, Rygiel AL, Ranasinghe S, Bruinooge SS, Schilsky RL. Alva AS, et al. Among authors: ranasinghe s. J Clin Oncol. 2021 Aug 1;39(22):2443-2451. doi: 10.1200/JCO.20.02923. Epub 2021 Apr 12. J Clin Oncol. 2021. PMID: 33844595 Clinical Trial.
Drugs for benign prostatic hypertrophy.
Jiwrajka M, Yaxley W, Ranasinghe S, Perera M, Roberts MJ, Yaxley J. Jiwrajka M, et al. Among authors: ranasinghe s. Aust Prescr. 2018 Oct;41(5):150-153. doi: 10.18773/austprescr.2018.045. Epub 2018 Oct 1. Aust Prescr. 2018. PMID: 30410211 Free PMC article. Review.
Echinococcus granulosus: Cure for Cancer Revisited.
Ranasinghe SL, McManus DP. Ranasinghe SL, et al. Front Med (Lausanne). 2018 Mar 12;5:60. doi: 10.3389/fmed.2018.00060. eCollection 2018. Front Med (Lausanne). 2018. PMID: 29594121 Free PMC article. Review.
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.
Penter L, Zhang Y, Savell A, Huang T, Cieri N, Thrash EM, Kim-Schulze S, Jhaveri A, Fu J, Ranasinghe S, Li S, Zhang W, Hathaway ES, Nazzaro M, Kim HT, Chen H, Thurin M, Rodig SJ, Severgnini M, Cibulskis C, Gabriel S, Livak KJ, Cutler C, Antin JH, Nikiforow S, Koreth J, Ho VT, Armand P, Ritz J, Streicher H, Neuberg D, Hodi FS, Gnjatic S, Soiffer RJ, Liu XS, Davids MS, Bachireddy P, Wu CJ. Penter L, et al. Among authors: ranasinghe s. Blood. 2021 Jun 10;137(23):3212-3217. doi: 10.1182/blood.2021010867. Blood. 2021. PMID: 33720354 Free PMC article. Clinical Trial.
Correction to: Schistosomiasis-from immunopathology to vaccines.
McManus DP, Bergquist R, Cai P, Ranasinghe S, Tebeje BM, You H. McManus DP, et al. Among authors: ranasinghe s. Semin Immunopathol. 2020 Jun;42(3):373-374. doi: 10.1007/s00281-020-00799-9. Semin Immunopathol. 2020. PMID: 32519147 Free PMC article.
CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase.
You H, Mayer JU, Johnston RL, Sivakumaran H, Ranasinghe S, Rivera V, Kondrashova O, Koufariotis LT, Du X, Driguez P, French JD, Waddell N, Duke MG, Ittiprasert W, Mann VH, Brindley PJ, Jones MK, McManus DP. You H, et al. Among authors: ranasinghe s. FASEB J. 2021 Jan;35(1):e21205. doi: 10.1096/fj.202001745RR. FASEB J. 2021. PMID: 33337558
Bioinformatic comparison of Kunitz protease inhibitors in Echinococcus granulosus sensu stricto and E. multilocularis and the genes expressed in different developmental stages of E. granulosus s.s.
Zhang H, Tian M, Qi W, Wu J, Zheng H, Guo G, Zhang L, Ranasinghe SL, McManus DP, Li J, Zhang W. Zhang H, et al. Among authors: ranasinghe sl. BMC Genomics. 2021 Dec 18;22(1):907. doi: 10.1186/s12864-021-08219-4. BMC Genomics. 2021. PMID: 34922456 Free PMC article.
106 results